March 20 | Symposium in Brussels: Hemoadsorption in critical ill patients – latest results and key learnings
Feb. 26 | Online Webinar (in german): Besonderheiten extrakorporaler Verfahren, 3-4pm CET
CytoSorbents & Hemoadsorption
When it comes to critical health challenges, count on us.
We understand that healthcare professionals need to be able to rely on technology that protects patients.
CytoSorbents’ powerful adsorption technology is expanding the dimensions of blood purification, with one of the fastest ways to restore balance and control damage – beyond what dialysis can do.
Our Innovation
The incomparable power of bead technology
Our solutions are based on our proprietary biocompatible, highly porous polymer bead technology, which works to effectively, safely, and selectively remove excessive levels of potentially harmful substances.
-
Our SolutionCytoSorb
Learn more about CytoSorbRestore balance to prevent damage
*Not available in the US
-
Our SolutionPuriFi
Learn more about PuriFiThe standalone platform tailored to CytoSorb®
*Not available in the US
-
Our SolutionECOS
Learn more about ECOSWorking with ex vivo organ perfusion to reduce inflammation
*Not available in the US
-
Our SolutionVetResQ
Learn more about VetResQThe power of CytoSorb for your pet’s health emergency
*Available only in the US
Use of CytoSorb in therapeutic areas
The CytoSorb adsorber is the basis for a blood purification therapy that removes a broad range of substances that, when at excessive levels, can be harmful to the body
Our Team of Experts
Expertise you can count on the moment you need it.
Voices around the world
Dr. Christopher Rugg
Innsbruck, AustriaCatecholamines decreased within 24 h after initiation of CytoSorb Therapy; in-hospital mortality was significantly lower in the CytoSorb group (35.7% vs 61.9%).
Assoc. Prof. Berna Kaya Ugur
Gaziantep, TurkeyUse of CytoSorb achieved significant decreases in endocan, copeptin, IL-6, procalcitonin and C-reactive protein levels.
Dr. Marine Peyneau
France, ParisCytoSorb appears to be safe and promising to fight post-lung transplantation inflammation, and should be re-evaluated in a larger study.